Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,120 | -1,541 | -7,317 | -4,898 | -4,008 |
| Depreciation Amortization | 16,838 | 8,467 | 32,637 | 23,974 | 15,649 |
| Accounts receivable | 607 | -6,911 | -7,388 | -5,501 | -4,980 |
| Accounts payable and accrued liabilities | 401 | 4,200 | 3,532 | 3,930 | 2,785 |
| Other Working Capital | -18,029 | -16,171 | -33,295 | -20,885 | -13,311 |
| Other Operating Activity | 4,105 | 4,662 | 16,418 | 8,373 | 7,028 |
| Operating Cash Flow | $-198 | $-7,294 | $4,587 | $4,993 | $3,163 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,933 | -1,605 | -8,848 | -6,796 | -5,466 |
| Net Acquisitions | N/A | N/A | -513 | -513 | -513 |
| Investing Cash Flow | $-4,933 | $-1,605 | $-9,361 | $-7,309 | $-5,979 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -774 | -413 | -1,974 | -1,378 | -959 |
| Common Stock Issued | 8,121 | 4,742 | 5,994 | 3,677 | 1,897 |
| Other Financing Activity | 0 | 0 | 1,255 | 1,210 | 979 |
| Financing Cash Flow | $7,347 | $4,329 | $5,275 | $3,509 | $1,917 |
| Exchange Rate Effect | 991 | 393 | 66 | 559 | 293 |
| Beginning Cash Position | 59,632 | 59,632 | 59,065 | 59,065 | 59,065 |
| End Cash Position | 62,839 | 55,455 | 59,632 | 60,817 | 58,459 |
| Net Cash Flow | $3,207 | $-4,177 | $567 | $1,752 | $-606 |
| Free Cash Flow | |||||
| Operating Cash Flow | -198 | -7,294 | 4,587 | 4,993 | 3,163 |
| Capital Expenditure | -4,933 | -1,605 | -8,848 | -6,796 | -5,466 |
| Free Cash Flow | -5,131 | -8,899 | -4,261 | -1,803 | -2,303 |